{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:06:35Z","timestamp":1753887995262,"version":"3.41.2"},"reference-count":25,"publisher":"FapUNIFESP (SciELO)","issue":"3","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Assoc. Med. Bras."],"DOI":"10.1590\/1806-9282.20230963","type":"journal-article","created":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T10:56:17Z","timestamp":1709549777000},"source":"Crossref","is-referenced-by-count":1,"title":["Relationship between skeletal muscle mass loss and metabolic dysfunction-associated fatty liver disease among Chinese patients with metabolic dysregulation"],"prefix":"10.1590","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2411-9295","authenticated-orcid":false,"given":"Miao","family":"Xu","sequence":"first","affiliation":[{"name":"Zhejiang University School of Medicine,  China; The First Affiliated Hospital of Ningbo University,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4417-9455","authenticated-orcid":false,"given":"Yi","family":"Lin","sequence":"additional","affiliation":[{"name":"University of Nottingham,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7439-723X","authenticated-orcid":false,"given":"Naibin","family":"Yang","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Ningbo University,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6930-9530","authenticated-orcid":false,"given":"Jialin","family":"Li","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Ningbo University,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6301-3544","authenticated-orcid":false,"given":"Li","family":"Li","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Ningbo University,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5175-3617","authenticated-orcid":false,"given":"Huiqing","family":"Ding","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Ningbo University,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6172-1253","authenticated-orcid":false,"given":"Chengfu","family":"Xu","sequence":"additional","affiliation":[{"name":"Zhejiang University School of Medicine,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2024]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi Z","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"8429847","DOI":"10.1155\/2022\/8429847","article-title":"Metabolic (dysfunction)-associated fatty liver disease in Chinese patients with type 2 diabetes from a subcenter of the national metabolic management center","volume":"2022","author":"Guan C","year":"2022","journal-title":"J Diabetes Res"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.3390\/ijerph17061818","article-title":"Prevalence and risk factors of metabolic associated fatty liver disease in Xinxiang, China","volume":"17","author":"Li H","year":"2020","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.14218\/JCTH.2021.00089","article-title":"Comparing the diagnostic criteria of MAFLD and NAFLD in the Chinese population: a population-based prospective cohort study","volume":"10","author":"Yu C","year":"2022","journal-title":"J Clin Transl Hepatol"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cger.2011.03.004","article-title":"The epidemiology of sarcopenia","volume":"27","author":"Janssen I","year":"2011","journal-title":"Clin Geriatr Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"101617","DOI":"10.1016\/j.arr.2022.101617","article-title":"Sarcopenia definition: does it really matter? Implications for resistance training","volume":"78","author":"Smith C","year":"2022","journal-title":"Ageing Res Rev"},{"issue":"9","key":"ref7","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1097\/MEG.0000000000001397","article-title":"Associations between sarcopenia and nonalcoholic fatty liver disease and advanced fibrosis in the USA","volume":"31","author":"Wijarnpreecha K","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"7","key":"ref8","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.cgh.2022.06.029","article-title":"Comparative burden of metabolic dysfunction in lean NAFLD vs non-lean NAFLD - a systematic review and meta-analysis","volume":"21","author":"Tang A","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3389\/fpubh.2019.00388","article-title":"Weight management programme for overweight and obese adults in Ningbo, China: a feasibility pre- and post-intervention study","volume":"7","author":"Xu M","year":"2019","journal-title":"Front Public Health"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"749302","DOI":"10.3389\/fpubh.2021.749302","article-title":"36-month evaluation of a weight management programme in Chinese overweight and obese adults","volume":"9","author":"Yang X","year":"2021","journal-title":"Front Public Health"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s12072-020-10094-2","article-title":"The Asian Pacific Association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease","volume":"14","author":"Eslam M","year":"2020","journal-title":"Hepatol Int"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"774030","DOI":"10.3389\/fnut.2021.774030","article-title":"Impact of sarcopenia on the severity of the liver damage in patients with non-alcoholic fatty liver disease","volume":"8","author":"Zambon Azevedo V","year":"2022","journal-title":"Front Nutr"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"afab272","DOI":"10.1093\/ageing\/afab272","article-title":"Prevalence and diagnostic agreement of sarcopenic obesity with different definitions among Chinese community-dwelling older adults","volume":"51","author":"Mo YH","year":"2022","journal-title":"Age Ageing"},{"issue":"8","key":"ref14","doi-asserted-by":"crossref","first-page":"e041879","DOI":"10.1136\/bmjopen-2020-041879","article-title":"Prevalence of sarcopenia in older Chinese adults: a systematic review and meta-analysis","volume":"11","author":"Xin C","year":"2021","journal-title":"BMJ Open"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","volume":"73","author":"Eslam M","year":"2020","journal-title":"J Hepatol"},{"year":"2000","series-title":"The Asia-Pacific perspective: redefining obesity and its treatment","key":"ref16"},{"issue":"9491","key":"ref17","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome--a new worldwide definition","volume":"366","author":"Alberti KG","year":"2005","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"739875","DOI":"10.3389\/fendo.2021.739875","article-title":"Validation of controlled attenuation parameter measured by fibroscan as a novel surrogate marker for the evaluation of metabolic derangement","volume":"12","author":"Huang Z","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"e91987","DOI":"10.1371\/journal.pone.0091987","article-title":"Non-invasive assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopy","volume":"9","author":"Karlas T","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12072-019-09964-1","article-title":"Relationship between relative skeletal muscle mass and nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"14","author":"Cai C","year":"2020","journal-title":"Hepatol Int"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s42000-022-00391-w","article-title":"Detangling the interrelations between MAFLD, insulin resistance, and key hormones","volume":"21","author":"Pal SC","year":"2022","journal-title":"Hormones (Athens)"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/liv.13301","article-title":"Pathology of non-alcoholic fatty liver disease","volume":"37 Suppl 1","author":"Bedossa P","year":"2017","journal-title":"Liver Int"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1559-4564.2007.06673.x","article-title":"The cardiometabolic syndrome and sarcopenic obesity in older persons","volume":"2","author":"Dominguez LJ","year":"2007","journal-title":"J Cardiometab Syndr"},{"issue":"10","key":"ref24","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.3390\/nu13103519","article-title":"Metabolic syndrome and sarcopenia","volume":"13","author":"Nishikawa H","year":"2021","journal-title":"Nutrients"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/MCO.0000000000000558","article-title":"Sarcopenic obesity in fatty liver","volume":"22","author":"Merli M","year":"2019","journal-title":"Curr Opin Clin Nutr Metab Care"}],"container-title":["Revista da Associa\u00e7\u00e3o M\u00e9dica Brasileira"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0104-42302024000300601&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T10:56:34Z","timestamp":1709549794000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0104-42302024000300601&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":25,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024]]}},"alternative-id":["S0104-42302024000300601"],"URL":"https:\/\/doi.org\/10.1590\/1806-9282.20230963","relation":{},"ISSN":["1806-9282","0104-4230"],"issn-type":[{"type":"electronic","value":"1806-9282"},{"type":"print","value":"0104-4230"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"e20230963"}}